Transparency Market Research Global Radiopharmaceuticals Market: Growing Demand for Radiopharmaceuticals for Cancer Treatment to Boost Market Expansion at 18.30% CAGR Published Date 127 Page Report 20-Feb-2013 Request Sample Buy Now Press Release http://www.transparencymarketresearch.com/pressrelease/radiopharmaceuticals-industry.htm Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com [email protected] Breast Pumps Market REPORT DESCRIPTION Growing Demand for Radiopharmaceuticals for Cancer Treatment to Boost Market Expansion at 18.30% CAGR According to a recent market research report released by Transparency Market Research, the global radiopharmaceuticals market is estimated to witness rapid expansion at a CAGR of 18.30% during the period between 2012 and 2018. The report, titled “Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 2018”, projects the global radiopharmaceuticals market to reach a valuation of US$12.2 bn by 2018. The overall market was worth US$3.8 bn in 2011. The report points out that the growing preference for disease-specific therapy, especially radiopharmaceutical-based cancer therapy, will boost the global radiopharmaceuticals market. Increasing awareness about accurate diagnosis, coupled with expanding molecular imaging applications, will push the growth of the market during the forecast horizon. However, the report mentions that strict regulatory guidelines for production, storage, and usage of radiopharmaceuticals will hamper the growth of the global radiopharmaceuticals market. Worldwide supply shortages, along with price sensitivity and the presence of competitive alternatives, will also negatively impact the overall market. The report states that the increasing demand for accurate diagnosis and treatment, particularly in emerging markets, and the rise of radiopharmaceutical-based personalized therapy will create new growth opportunities for the global radiopharmaceuticals market. Enquiry before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id= Overview of the companion diagnostics market On the basis of type of radioactive isotope, the report segments the global radiopharmaceuticals market into Mo-99/Tc99m generators, Sr-82/Rb-82 generators, Ge-68/Ga-67,68 generators, W-188/Re-188 generators, and Sr-90/Y-90 generators. So far, Mo-99/Tc-99m generators have dominated the overall market owing to their established marketing 2 Transparency Market Research Breast Pumps Market channels. However, during the forecast horizon, it is expected that other segments of the market will witness growth at double-digit CAGRs. Depending on application, the report categorizes the global radiopharmaceuticals market into diagnosis and therapy. The usage of radiopharmaceuticals for diagnosis includes the techniques of SPECT and PET, wherein radiopharmaceuticals are applied for the diagnosis of cardiovascular disorders, cancer, neurological disorders, thyroid diseases, and gastrointestinal disorders. The usage of radiopharmaceuticals for therapy includes various isotopes used in oncology, neurology, and cardiology. Oncology dominates the overall market for radiopharmaceuticals. While treating cancer, these radioactive agents target the cancerous areas in the body to destroy the affected tissues. Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/radiopharmaceuticals-industry.htm TABLE OF CONTENT Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology Chapter 2 Executive Summary Chapter 3 Global Radiopharmaceuticals Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Radiopharmaceutical-Based Cancer Therapy 3.2.2 Growing Preference For Disease-Targeted Therapy 3 Transparency Market Research Breast Pumps Market 3.2.3 Increasing Awareness Of Accurate Diagnosis 3.2.4 Expanding Molecular Imaging Applications 3.3 Market Restraints 3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage 3.3.2 Worldwide Supply Shortages 3.3.3 Price Sensitivity And Competitive Alternatives 3.4 Market Opportunities 3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In Emerging Markets 3.4.2 Radiopharmaceutical-Based Personalized Therapy Chapter 4 Market Definition & Supply Chain Analysis 4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis Chapter 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million) 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups 6.1 Overview 6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million) 6.2 Hospitals and Medical Centers 6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical Centres, 2010 – 2018 (USD Million) 6.3 Outpatient Diagnostic Centers 4 Transparency Market Research Breast Pumps Market 6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million) Chapter 7 Global Radiopharmaceuticals Market, By Applications 7.1 Overview 7.2 Radiopharmaceuticals For Diagnosis 7.2.1 Overview 7.2.2 Radiopharmaceuticals For Diagnosis, By Technique 7.2.2.1 Single-Photon Emission Computed Tomography (SPECT) 7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%) 7.2.2.1.2 Technetium (Tc-99m) 7.2.2.1.3 Thallium (Tl-201) 7.2.2.1.4 Gallium (Ga-67) 7.2.2.1.5 Iodine (I-123) 7.2.2.1.6 Rhenium (Re-186) 7.2.2.1.7 Yttrium (Y-90) 7.2.2.1.8 Others 7.2.2.2 Positron Emission Tomography (PET) 7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%) 7.2.2.2.2 Fludeoxyglucose (18f-FDG) 7.2.2.2.3 Rubidium (Rb-82) 7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia) 7.2.3 Radiopharmaceuticals For Diagnosis, By Indications 7.2.3.1 Oncology 7.2.3.2 Cardiovascular 7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal) 7.3 Radiopharmaceuticals For Therapy 7.3.1 Overview 7.3.2 Oncology (Systemic Therapy) 7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%) 7.3.2.2 Iodine (I-131) 7.3.2.3 Yttrium (Y-90) 5 Transparency Market Research Breast Pumps Market 7.3.2.4 Samarium (Sm-153) 7.3.2.5 Strontium (Sr-89) 7.3.2.6 Rhenium (186Re) 7.3.2.7 Lutetium-177 (Lu-177) 7.3.2.8 Erbium-169 (169Er) 7.3.2.9 Others 7.3.3 Other Applications In Therapy (Cardiology, Neurology) 7.4 Theranostics Chapter 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy, 2010-2018 (USD Million) 8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million) 8.3 Europe 8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million) 8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million) 8.4 Asia-Pacific (Apac) 8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million) 8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million) 8.5 Rest of the World (RoW) 8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million) 8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million) Chapter 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market Chapter 10 Recommendations 10.1 Identification and Elimination Of Barriers 10.2 Development of Total Solutions 6 Transparency Market Research Breast Pumps Market 10.3 Investing in Emerging Markets 10.4 Entering Monopoly Markets Chapter 11 Company Profiles 11.1 Cardinal Health Inc. 11.1.1 Company Overview 11.1.2 Financial Overview 11.1.3 Business Strategies 11.1.3.1 Mergers and Acquisitions 11.1.3.2 External Funding 11.1.3.3 Incorporation of Advanced Technologies to Support Business Development 11.1.4 Product Portfolio 11.1.5 Recent Developments 11.2 Covidien Plc 11.2.1 Company Overview 11.2.2 Product Portfolio 11.2.3 Financial Overview 11.2.4 Strategic Overview 11.2.4.1 Mergers and Acquisitions 11.2.4.2 Approvals 11.2.5 Recent Developments 11.3 GE Healthcare 11.3.1 Company Overview 11.3.2 Product Portfolio 11.3.3 Financial Overview 11.3.4 Strategic Overview 11.3.4.1 Mergers and Acquisitions 11.3.5 Recent Developments 11.4 IBA Group 11.4.1 Company Overview 11.4.2 Financial Overview 7 Transparency Market Research Breast Pumps Market 11.4.3 Product Portfolio 11.5 Lantheus Medical Imaging 11.5.1 Company Overview 11.5.2 Financial Overview 11.5.3 Business Strategies 11.5.3.1 Rigorous Research and Development Initiatives 11.5.3.2 Selling Generic Products to Maintain Market Share 11.5.4 Product Portfolio 11.5.4.1 Recent Developments 11.6 Monrol Nuclear Products, Inc. 11.6.1 Company Overview 11.6.2 Product Portfolio 11.6.3 Strategic Overview 11.6.3.1 Mergers and Acquisitions 11.6.3.2 Collaborations 11.6.4 Recent Developments 11.7 Nordion, Inc. 11.7.1 Company Overview 11.7.2 Product Portfolio 11.7.3 Financial Overview 11.7.4 Strategic Overview 11.7.4.1 Contracts and Agreements 11.7.4.2 Divestiture 11.7.5 Recent Developments 11.7.5.1 New Product Launch 11.8 NTP Radioisotopes (Pty) Ltd 11.8.1 Company Overview 11.8.2 Financial Overview 11.8.3 Business Strategies 11.8.3.1 Media Campaigns as a Brand Management Tool 11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances 8 Transparency Market Research Breast Pumps Market 11.8.4 Product Portfolio 11.8.5 Recent Developments 11.9 Polatom 11.9.1 Company Overview 11.9.2 Financial Overview 11.9.3 Business Strategies 11.9.3.1 Maintaining an Extensive Network of Distributors 11.9.4 Product Portfolio 11.9.5 Recent Developments 11.10 Positron Corporation 11.10.1 Company Overview 11.10.2 Product Portfolio 11.10.3 Financial Overview 11.10.4 Strategic Overview 11.10.4.1 Contracts and Agreements 11.10.4.2 Collaborations 11.10.5 Recent Developments 11.10.5.1 Grants and Licenses 11.10.5.2 Incentives 11.11 Siemens Healthcare 11.11.1 Company Overview 11.11.2 Financial Overview 11.11.3 Business Strategies 11.11.3.1 Investing In Emerging Economies 11.11.3.2 Rigorous Research and Development Initiatives 11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals (Agenda 2013) 11.11.3.4 Maintaining An Extensive Suppliers Network 11.11.4 Product Portfolio 11.11.5 Recent Developments 9 Transparency Market Research Breast Pumps Market About Us Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/ 10 Transparency Market Research
According to a recent market research report released by Transparency Market Research, the global radiopharmaceuticals market is estimated to witness rapid expansion at a CAGR of 18.30% during the period between 2012 and 2018. The report, titled “Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”, projects the global radiopharmaceuticals market to reach a valuation of US$12.2 bn by 2018. The overall market was worth US$3.8 bn in 2011.
© Copyright 2024 Paperzz
